CN115671201A - Traditional Chinese medicine plaster for treating premature beat - Google Patents

Traditional Chinese medicine plaster for treating premature beat Download PDF

Info

Publication number
CN115671201A
CN115671201A CN202110854822.6A CN202110854822A CN115671201A CN 115671201 A CN115671201 A CN 115671201A CN 202110854822 A CN202110854822 A CN 202110854822A CN 115671201 A CN115671201 A CN 115671201A
Authority
CN
China
Prior art keywords
parts
chinese medicine
traditional chinese
fried
heart
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202110854822.6A
Other languages
Chinese (zh)
Other versions
CN115671201B (en
Inventor
唐靖一
马子霖
沈琳
王雲
黄嘉滢
赵外荣
程天翊
潘宇炯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Longhua Hospital Affiliated to Shanghai University of TCM
Original Assignee
Longhua Hospital Affiliated to Shanghai University of TCM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Longhua Hospital Affiliated to Shanghai University of TCM filed Critical Longhua Hospital Affiliated to Shanghai University of TCM
Priority to CN202110854822.6A priority Critical patent/CN115671201B/en
Publication of CN115671201A publication Critical patent/CN115671201A/en
Application granted granted Critical
Publication of CN115671201B publication Critical patent/CN115671201B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine application for treating premature beat, which comprises a spunlace non-woven fabric blank patch and an extract coated in the middle of the spunlace non-woven fabric blank patch, wherein the extract comprises a traditional Chinese medicine composition and a dressing, and the traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 120-240 parts of codonopsis pilosula, 120-240 parts of fried bighead atractylodes rhizome, 40-80 parts of honey-fried licorice root, 40-80 parts of rhizoma acori graminei, 60-120 parts of schisandra chinensis, 60-120 parts of platycladi seed, 120-240 parts of poria cocos, 120-240 parts of astragalus membranaceus, 60-120 parts of salvia miltiorrhiza, 40-80 parts of mangnolia officinalis, 60-120 parts of angelica sinensis, 40-80 parts of prepared polygala tenuifolia, 100-200 parts of nardostachys chinensis, 40-80 parts of cinnamon, 60-120 parts of fried spina date seed, 60-120 parts of radix ophiopogonis, 40-80 parts of menthol and 20-40 parts of borneol. The medicines in the Chinese medicinal application paste are compatible, complement each other, play a role of strengthening body resistance and banking up root together, benefit qi and nourish blood, activate blood and dissolve stasis, and calm heart and tranquilize mind, have the advantages of obvious effect, exact medicinal effect and quick response, and are worthy of clinical popularization and application.

Description

Traditional Chinese medicine plaster for treating premature beat
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine plaster for treating premature beat.
Background
Cardiovascular diseases have become the main cause of premature death of Chinese at present. Arrhythmia, a common cardiovascular disease, can be one of the accompanying symptoms of other diseases as well as the early or only clinical manifestations of heart abnormalities. In recent 30 years, the average annual incidence rate of sudden cardiac death events in China was 0.04%, and about 50% -70% of sudden cardiac death was associated with ventricular tachyarrhythmia.
At present, for the western medicine treatment of ventricular premature contraction, the '2020 ventricular arrhythmia Chinese specialist consensus' indicates that for a patient suspected of ventricular premature contraction induced cardiomyopathy, the ventricular premature is to be treated actively. For premature ventricular patients without organic heart disease, application of too aggressive a therapeutic strategy is not recommended. Although beta blockers or non-dihydropyridine calcium channel blockers may be used as appropriate, there is no evidence of their effectiveness for a while, and calcium channel blockers themselves may cause significant symptoms such as palpitations, headache, and fatigue. While the systems for catheter ablation therapy are well established, their invasive procedures, strict indications and their high cost are still prohibitive to some patients.
Disclosure of Invention
In view of the above disadvantages in the prior art, according to the embodiments of the present invention, it is desirable to provide a Chinese medicine patch for treating premature beat, which aims to solve the problems of poor treatment effect and high price when the existing medicine is used for treating premature beat.
According to the embodiment, the traditional Chinese medicine application for treating premature beat comprises a spunlace non-woven fabric blank patch and an extract coated in the middle of the spunlace non-woven fabric blank patch, wherein the extract comprises a traditional Chinese medicine composition and a dressing, and the traditional Chinese medicine application is characterized in that the traditional Chinese medicine composition comprises the following raw medicines in parts by weight: 120-240 parts of codonopsis pilosula, 120-240 parts of fried bighead atractylodes rhizome, 40-80 parts of honey-fried licorice root, 40-80 parts of rhizoma acori graminei, 60-120 parts of schisandra chinensis, 60-120 parts of platycladi seed, 120-240 parts of poria cocos, 120-240 parts of astragalus membranaceus, 60-120 parts of salvia miltiorrhiza, 40-80 parts of mangnolia officinalis, 60-120 parts of angelica sinensis, 40-80 parts of prepared polygala tenuifolia, 100-200 parts of nardostachys chinensis, 40-80 parts of cinnamon, 60-120 parts of fried spina date seed, 60-120 parts of radix ophiopogonis, 40-80 parts of menthol and 20-40 parts of borneol.
According to one embodiment, in the traditional Chinese medicine application for treating premature beat, the traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 180 parts of codonopsis pilosula, 180 parts of fried bighead atractylodes rhizome, 60 parts of honey-fried licorice root, 60 parts of grassleaf sweelflag rhizome, 90 parts of Chinese magnoliavine fruit, 90 parts of platycladi seed, 150 parts of poria cocos, 180 parts of astragalus membranaceus, 90 parts of salvia miltiorrhiza, 60 parts of magnolia officinalis, 90 parts of Chinese angelica, 60 parts of prepared polygala root, 150 parts of nardostachys root, 60 parts of cinnamon, 90 parts of fried spina date seed, 90 parts of dwarf lilyturf tuber, 60 parts of menthol and 30 parts of borneol.
According to one embodiment, in the traditional Chinese medicine application for treating premature beat, the extract is a big honeyed pill, the dressing is honey, eighteen raw material medicines of the traditional Chinese medicine composition are crushed into fine powder, sieved, mixed uniformly, and added with a proper amount of honey to prepare the big honeyed pill.
In the traditional Chinese medicine application paste, the codonopsis pilosula is sweet in taste and neutral in nature, enters lung and spleen channels, and has the effects of tonifying middle-jiao and Qi, invigorating spleen and nourishing blood to promote the production of body fluid; astragalus root, radix astragali, sweet in flavor and slightly warm in nature, enters lung and spleen channels, and can tonify qi, raise yang, induce diuresis to alleviate edema, and is the essential drug for tonifying qi; the fried bighead atractylodes rhizome is sweet and bitter in taste and warm in nature, enters spleen and stomach channels, strengthens spleen and tonifies qi, eliminates dampness and promotes diuresis; poria has sweet and light taste and neutral nature, and has effects in invigorating spleen, tranquilizing mind, promoting diuresis and eliminating dampness; prepared licorice root, radix Glycyrrhizae Praeparata, sweet in taste, neutral in nature, enters heart, lung, spleen and stomach channels, and has the effects of tonifying heart qi, restoring heart pulse, benefiting spleen qi, promoting transportation and transformation, nourishing yin and blood, restoring pulse and stopping palpitation. "the book of changes" cloud: to impair the heart, nourish the heart. The treatment should be done exclusively for true blood, which is abundant, so it is not enough to be treated with assistance by heart. The traditional Chinese medicine composition is a monarch drug, can tonify qi and spleen, the spleen is a source for generating and transforming qi and blood, the spleen and the stomach are strong and strong due to the splenic qi, once the transportation and transformation functions of the spleen and the stomach are recovered, the qi and the blood can be naturally generated and continuously generated, and the heart and the blood are sufficient, so that the spirit can be calmed. The angelica is sweet and pungent in flavor and warm in nature, belongs to liver, heart and spleen channels, can tonify blood and activate blood circulation, is a key blood-enriching medicine, is compatible with the astragalus root, can tonify qi and produce blood by combining the two medicines, and can nourish and transform the qi, so as to tonify qi, consolidate blood and promote qi and blood circulation. The fried spina date seed is sweet and sour in taste and neutral in nature, enters heart, liver and gallbladder channels, calms heart, soothes nerves, nourishes heart and promotes the production of body fluid; the polygala root prepared is bitter and pungent in taste and slightly warm in nature, enters heart, kidney and lung channels, soothes nerves, benefits intelligence and communicates heart and kidney, and is recorded in famous medical records: "Heart-nourishing and tranquilizing", heart-nourishing and blood-relieving, convulsion-relieving, heart-calming, phlegm-dispersing and saliva-dispersing "is also emphasized in Dian nan materia Medica" for "heart-nourishing and tranquilizing", because it can calm heart qi, stop palpitation, replenish vital essence, dispel heart-qi and heat in the skin, face and eye. Treating epilepsy, opisthotonus, convulsion, expectoration, shaking hands and feet, constipation, urination, reddish and whitish turbidity, stranguria with chyluria, and spermatorrhea. The schisandra chinensis has the functions of invigorating qi, promoting the production of body fluid, tonifying kidney, calming heart and tranquilizing mind; baizi ren is sweet in flavor and neutral in nature, and enters heart, kidney and large intestine meridians, and has the actions of nourishing heart and tranquilizing mind. The medicines enter heart meridian, enrich blood and nourish heart, and calm heart and tranquilize mind. Radix aucklandiae has the effects of regulating qi and activating spleen, so that the tonifying effect is realized without stagnation. The dwarf lilyturf tuber is sweet and slightly bitter in taste and slightly cold in nature, belongs to heart, lung and stomach channels, clears heart, relieves restlessness, nourishes yin and promotes the production of body fluid; magnolia bark, cortex magnoliae officinalis, radix seu folium magnoliae officinalis is warm in nature, enters spleen, stomach, lung, large intestine channels, eliminates dampness and phlegm, and dispels the depressed liver and binds, and is mentioned in Shen nong's herbal Jing: it is used to treat apoplexy, typhoid, headache, cold and heat, palpitation, qi and blood stagnation, muscle death and three pests. Rhizoma acori graminei enters heart and stomach channels, phlegm is eliminated, resuscitation is brought to mind, and the palpitation, the insomnia and the amnesia caused by malnutrition of heart and mind are treated; the salvia miltiorrhiza is bitter in taste and slightly warm, enters heart and liver channels, can cool blood, clear heart and relieve restlessness, has the functions of nourishing heart and soothing nerves, and has the effect of invigorating blood circulation and removing blood stasis in ancient people, namely Yun Yiwei salvia miltiorrhiza powder which is similar to the four-ingredient decoction. The whole formula has proper compatibility, so that the traditional Chinese medicine can tonify without stagnation, and can promote blood circulation without damaging healthy energy.
Modern pharmacology indicates that: astragalus has the functions of strengthening heart, promoting urination and increasing cardiac output, and the mechanism of the protective effect mediated by astragaloside as the main component of astragalus probably relates to improving the function of heart and reducing the oxidative damage of myocardium by reducing MDA, maintaining SOD and reducing the damage of myocardial cells induced by free radicals. In addition, eAM works by blocking Ca 2+ Blocking cell death and opening mitochondrial K ATP Channels to enhance the viability of cardiomyocytes to reduce apoptosis; the codonopsis pilosula has a great inhibition effect on acute myocardial ischemia, particularly caused by pituitrin; the salvia miltiorrhiza and the angelica have the effect of dilating coronary arteries and have a certain degree of prevention effect on arrhythmia of patients suffering from myocardial ischemia reperfusion; the spina date seed can reduce the occurrence probability of arrhythmia events caused by medicaments, particularly chloroform, aconitine, barium chloride and other medicaments; the calamus oil in the grassleaf sweelflag rhizome can resist various atrial and ventricular arrhythmias of experimental animals; the ophiopogon root has positive inotropic effect and obvious arrhythmia resisting effect.
As a specific component in the external medicine, the borneol is pungent in taste and cool in nature, and has the effect of entering heart, spleen and lung channels without being held; the mint is pungent in flavor and cool in nature, enters lung and liver meridians, and has the effects of inducing resuscitation and refreshing mind as a pair of permeation-promoting medicines, and can bring cool feeling to skin when being locally externally used. It has been demonstrated that topical application of menthol increases blood flow in the skin microvasculature and that the effect is dose dependent. This increase in local blood flow is mediated by the sensory nerves and EDHF. In addition, the borneol is used as a permeability enhancer, so that quite satisfactory performance is presented, the borneol has relatively low toxicity on skin cells, and obvious skin irritation is not generated by the borneol with proper concentration, so that a good foundation is laid for local external application of acupoint application.
In the traditional Chinese medicine application paste, the components are reasonably matched, the medicine formula is strict, and the pathogenesis of the premature beat is determined as follows: deficiency of both qi and blood of the heart and spleen. Has the functions of replenishing qi to invigorate the spleen, nourishing the heart, soothing the nerves and stabilizing palpitation aiming at main pathogenesis. Clinical data prove that the formula has definite clinical curative effect and no obvious adverse reaction and toxic or side effect. The traditional Chinese medicine composition can improve the cardiac function of a patient with premature beat, reduce the oxidative damage of myocardial cells and balance the autonomic nerve function by replenishing qi to invigorate the spleen, nourishing the heart to calm the nerves and stabilizing palpitation, thereby relieving clinical symptoms.
The Chinese medicinal patch can improve the cardiac function of a patient with premature beat, reduce the oxidative damage of myocardial cells and balance the function of autonomic nerve. The Chinese medicinal herbs are compatible and complement each other, so that the Chinese medicinal herbs have the effects of strengthening body resistance and banking up root together, tonifying qi and nourishing blood, activating blood and dissolving stasis, and calming heart and soothing nerves, have the advantages of good and quick response, are obvious in effect, exact in medicinal effect and quick in response, and are worthy of clinical popularization and application.
Detailed Description
The invention will be further illustrated with reference to the following specific examples. These examples are to be construed as merely illustrative and not limitative of the remainder of the disclosure in any way whatsoever. After reading the description of the invention, one skilled in the art can make various changes and modifications to the invention, and such equivalent changes and modifications also fall into the scope of the invention defined by the claims.
Examples
Weighing 180 g of codonopsis pilosula, 180 g of fried bighead atractylodes rhizome, 60 g of honey-fried licorice root, 60 g of grassleaf sweelflag rhizome, 90 g of Chinese magnoliavine fruit, 90 g of platycladi seed, 150 g of poria cocos, 180 g of astragalus membranaceus, 90 g of salvia miltiorrhiza, 60 g of mangnolia officinalis, 90 g of Chinese angelica, 60 g of prepared polygala tenuifolia, 150 g of nardostachys root, 60 g of cinnamon, 90 g of fried spina date seed, 90 g of radix ophiopogonis, 60 g of menthol and 30 g of borneol, crushing the raw materials into fine powder, sieving the fine powder, uniformly mixing the fine powder, adding a proper amount of honey to prepare a large honeyed pill with the diameter of 1cm, coating the large honeyed pill in the middle of a spunlace non-woven fabric blank patch to prepare a traditional Chinese medicine patch (hereinafter called a Ningxin patch) for later use.
Experimental example (Chinese medicine application)
(1) First stage (lead-in period: -1-0 week)
Patients in this stage are treated with consistent health education and anti-arrhythmic drug therapy (oral propafenone hydrochloride tablets) according to the treatment method recommended by the national experts consensus on ventricular arrhythmia (the society for medical science of China, the division of electrocardio-physiology and pacing, the committee of the institute of cardiac rhythm professional, 2016).
(2) Second stage (treatment period: 1-4 weeks)
(1) Treatment group (ningxin plaster group) (35 persons): oral propafenone hydrochloride tablets and external use mind-calming patches;
the medication method comprises the following steps: oral propafenone hydrochloride tablet (3 times daily, 100mg each time) + external use heart calming plaster
The usage and dosage of the heart calming plaster are as follows: big honeyed pill with diameter of 1cm is applied to Neiguan acupoint on both sides once a day for 6 hr each time. 4 weeks is a course of treatment.
(2) Control group (35 persons): the propafenone hydrochloride tablet is taken orally.
The medication method comprises the following steps: propafenone hydrochloride tablets (3 times daily, 100mg each time) were taken orally.
The therapeutic effects of the treatment groups and the control group after completion of the treatment are shown in the following tables 1 to 4.
As can be seen from the table, the application of the Chinese medicine patch can effectively reduce the number of premature beats and various symptoms caused by the premature beats, and has good treatment effect on the premature beats.
TABLE 1 comparison of the total number of ventricular premature beats before and after treatment in two groups of patients (M (Q25-Q45))
Figure BDA0003183737680000051
Note: compared with the treatment before the treatment, * P<0.05, ** p is less than 0.01; compared with the control group, the compound of the formula, P<0.05, △△ P<0.01。
TABLE 2 Compare the ventricular premature response of the two groups of patients
Figure BDA0003183737680000052
Note: compared with the treatment before the treatment, * P<0.05, ** p is less than 0.01; compared with the control group, the compound of the formula, P<0.05, △△ P<0.01。
TABLE 3 comparison of the Chinese medical syndrome integral before and after treatment of two groups of patients
Figure BDA0003183737680000053
Figure BDA0003183737680000054
Note: compared with the treatment before the treatment, * P<0.05, ** p is less than 0.01; compared with the control group, the compound of the formula, P<0.05, △△ P<0.01。
TABLE 4 comparison of the therapeutic effects of the two groups of patients
Figure BDA0003183737680000061
Note: compared with the treatment before the treatment, * P<0.05, ** p is less than 0.01; compared with the control group, the compound of the formula, P<0.05, △△ P<0.01。

Claims (3)

1. a traditional Chinese medicine application for treating premature beat comprises a spunlace non-woven fabric blank patch and an extract coated in the middle of the spunlace non-woven fabric blank patch, wherein the extract comprises a traditional Chinese medicine composition and a dressing, and is characterized in that the traditional Chinese medicine composition is composed of the following raw medicines in parts by weight: 120-240 parts of codonopsis pilosula, 120-240 parts of fried bighead atractylodes rhizome, 40-80 parts of honey-fried licorice root, 40-80 parts of rhizoma acori graminei, 60-120 parts of schisandra chinensis, 60-120 parts of platycladi seed, 120-240 parts of poria cocos, 120-240 parts of astragalus membranaceus, 60-120 parts of salvia miltiorrhiza, 40-80 parts of mangnolia officinalis, 60-120 parts of angelica sinensis, 40-80 parts of prepared polygala tenuifolia, 100-200 parts of nardostachys chinensis, 40-80 parts of cinnamon, 60-120 parts of fried spina date seed, 60-120 parts of radix ophiopogonis, 40-80 parts of menthol and 20-40 parts of borneol.
2. The traditional Chinese medicine plaster for treating premature beat according to claim 1, wherein the traditional Chinese medicine composition is prepared from the following raw materials in parts by weight: 180 parts of codonopsis pilosula, 180 parts of fried bighead atractylodes rhizome, 60 parts of honey-fried licorice root, 60 parts of grassleaf sweelflag rhizome, 90 parts of Chinese magnoliavine fruit, 90 parts of platycladi seed, 150 parts of poria cocos, 180 parts of astragalus membranaceus, 90 parts of salvia miltiorrhiza, 60 parts of magnolia officinalis, 90 parts of Chinese angelica, 60 parts of prepared polygala root, 150 parts of nardostachys root, 60 parts of cinnamon, 90 parts of fried spina date seed, 90 parts of dwarf lilyturf tuber, 60 parts of menthol and 30 parts of borneol.
3. The traditional Chinese medicine plaster for treating premature beat according to claim 1 or 2, wherein the extract is a big honeyed pill, the dressing is honey, eighteen raw material medicines of the traditional Chinese medicine composition are crushed into fine powder, sieved, mixed evenly, added with a proper amount of honey and prepared into a big honeyed pill.
CN202110854822.6A 2021-07-28 2021-07-28 Traditional Chinese medicine application for treating premature beat Active CN115671201B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110854822.6A CN115671201B (en) 2021-07-28 2021-07-28 Traditional Chinese medicine application for treating premature beat

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110854822.6A CN115671201B (en) 2021-07-28 2021-07-28 Traditional Chinese medicine application for treating premature beat

Publications (2)

Publication Number Publication Date
CN115671201A true CN115671201A (en) 2023-02-03
CN115671201B CN115671201B (en) 2023-07-11

Family

ID=85058132

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110854822.6A Active CN115671201B (en) 2021-07-28 2021-07-28 Traditional Chinese medicine application for treating premature beat

Country Status (1)

Country Link
CN (1) CN115671201B (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1362081A (en) * 2001-01-05 2002-08-07 杨孟君 Nano tranquilizing cinnabar medicine and its preparation
CN103110805A (en) * 2013-01-09 2013-05-22 胡夫东 Traditional Chinese medicine composition for treating manic episodes caused by mood disorders and preparation method thereof
CN103520288A (en) * 2011-07-28 2014-01-22 冯亚西 External drug for treating heart disease and vasculitis, and its application
CN104547939A (en) * 2015-01-15 2015-04-29 安乐红 Traditional Chinese medicine preparation for treating premature beat
CN105267862A (en) * 2015-08-28 2016-01-27 董春丽 Traditional Chinese medicine composition for treating ventricular premature beat
CN107233476A (en) * 2017-05-31 2017-10-10 成都风靡生物科技有限公司 It is a kind of to treat Chinese medicine composition easily awake more than dysphoria and insomnia, palpitation palpitation with fear and dream
CN110893187A (en) * 2018-09-13 2020-03-20 上海中医药大学附属龙华医院 Application of tanshinone IIA sodium sulfonate in preparation of medicine for treating acute or chronic diseases accompanied with increase of homocysteine in blood

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1362081A (en) * 2001-01-05 2002-08-07 杨孟君 Nano tranquilizing cinnabar medicine and its preparation
CN103520288A (en) * 2011-07-28 2014-01-22 冯亚西 External drug for treating heart disease and vasculitis, and its application
CN103110805A (en) * 2013-01-09 2013-05-22 胡夫东 Traditional Chinese medicine composition for treating manic episodes caused by mood disorders and preparation method thereof
CN104547939A (en) * 2015-01-15 2015-04-29 安乐红 Traditional Chinese medicine preparation for treating premature beat
CN105267862A (en) * 2015-08-28 2016-01-27 董春丽 Traditional Chinese medicine composition for treating ventricular premature beat
CN107233476A (en) * 2017-05-31 2017-10-10 成都风靡生物科技有限公司 It is a kind of to treat Chinese medicine composition easily awake more than dysphoria and insomnia, palpitation palpitation with fear and dream
CN110893187A (en) * 2018-09-13 2020-03-20 上海中医药大学附属龙华医院 Application of tanshinone IIA sodium sulfonate in preparation of medicine for treating acute or chronic diseases accompanied with increase of homocysteine in blood

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
刘春燕,等: "复律宁颗粒治疗气阴两虚型或心血亏虚型心悸(室性早搏)的临床研究", 中华中医药杂志, vol. 32, no. 12, pages 5675 - 5677 *
孟祥敏,等: "中医药抗心律失常的研究进展", 中国医药导刊, vol. 10, no. 08, pages 1181 - 1182 *
王晖: "归脾汤合生脉散治疗室性早搏的体会", 实用医技杂志, vol. 15, no. 14, pages 1829 - 1830 *
王雲,等: "宁心贴穴位贴敷联合西药治疗心脾两虚型室性早搏的临床观察", 上海中医药杂志, vol. 56, no. 07, pages 63 - 67 *
胡国龙,等: "归脾汤加味治疗心律不齐26例", 四川中医, no. 04, pages 31 *
赵新峰: "养心汤治疗冠心病148例", 辽宁中医杂志, no. 04, pages 471 *

Also Published As

Publication number Publication date
CN115671201B (en) 2023-07-11

Similar Documents

Publication Publication Date Title
CN106376820A (en) Solid drink for dispelling stomach cold and protecting gastric mucosa and preparation method thereof
CN105031525B (en) A kind of Chinese medicine preparation of brain healthy and preparation method thereof
CN106880826A (en) A kind of Chinese medicine preparation of chronic heart failure and preparation method thereof
CN109288994A (en) A kind of hypolipemic ' Tongluowan ' prescription and its preparation process
CN104606561A (en) Traditional Chinese medicinal composition for treating spontaneous perspiration
CN104474129A (en) Medicinal formula for treating coronary heart disease and use method thereof
CN115671201A (en) Traditional Chinese medicine plaster for treating premature beat
CN103393986A (en) Traditional Chinese medicine composition for treating hepatitis b cirrhosis and preparation method thereof
CN104740465A (en) Traditional Chinese medicine composition for treating allergic rhinitis
CN105232677A (en) Traditional Chinese medicine composition for treating myocardial infarction and preparation method of traditional Chinese medicine composition
CN105055919A (en) Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases
CN103961555A (en) Traditional Chinese medicine preparation for treating peripheral nerve injury and preparation method thereof
CN104258351A (en) Traditional Chinese medicine preparation for treating alcoholic cardiomyopathy and preparation method of preparation
CN103055172A (en) Chinese medicinal composition for treating leucoderma
CN104524535B (en) It is a kind of to treat Chinese medicine composition of chronic cor pulmonale and preparation method thereof
CN114504635B (en) Chinese patent medicine for treating apoplexy sequela
CN103110877B (en) Traditional Chinese medicine preparation for treating rheumatic heart disease
CN111407868B (en) Traditional Chinese medicine pill for improving cognitive function of brain
CN101983712A (en) Novel medicament for treating coronary heart disease
Chang et al. The anti-inflammatory effects of Chinese herbs, plants, and spices
CN107213219A (en) Treat the Chinese medicine preparation of cardiovascular and cerebrovascular disease
CN105267694B (en) A kind of ginseng health care tea improving coronary heart disease
CN106176996A (en) A kind of Chinese medicine composition of facial paralysis
CN117599125A (en) A Chinese medicinal composition for supplementing calcium and strengthening bones for treating osteoporosis, and its preparation method and application
CN114668817A (en) Pharmaceutical formulation for treating arrhythmia and postoperative recovery of heart

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant